Published August 2, 2022 | Version v1
Patent Open

Development of new monoclonal antibodies recognizing human prostate-specific membrane antigen (PSMA)

  • 1. University of Chicago
  • 2. University of Michigan

Description

Provided herein are compositions and methods for the inhibition of enteric infection. In particular, compositions comprising bacteria of the class Clostridia are administered to human and/or animal subjects to prevent or decrease susceptibility to enteric infection.

Files

US11400121.pdf

Files (2.0 MB)

Name Size Download all
md5:e8156516b55c5f01c0471bead131e348
2.0 MB Preview Download

Additional details

Identifiers

Patent number
US 11400121 B2
Patent application number
US 201816476216 A
Other
oai:uchicago.tind.io:7397

Dates

Patent filed
2018-01-05

UChicago Information

Division(s)
Pritzker School of Molecular Engineering, Biological Sciences Division
Department(s)
Immunology